| Identification | More | [Name]
trans-3,4-Difluorocinnamic acid | [CAS]
112897-97-9 | [Synonyms]
3,4-DIFLUOROCINNAMIC ACID
AKOS 92715
RARECHEM BK HW 0122
TIMTEC-BB SBB006677
TRANS-3,4-DIFLUOROCINNAMIC ACID
trans-3,4-Difluorocinnamic acid 97%
trans-3,4-Difluorocinnamicacid97% | [Molecular Formula]
C9H6F2O2 | [MDL Number]
MFCD00010320 | [Molecular Weight]
184.14 | [MOL File]
112897-97-9.mol |
| Safety Data | Back Directory | [Hazard Codes ]
Xi | [Risk Statements ]
R36/37/38:Irritating to eyes, respiratory system and skin . | [Safety Statements ]
S26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice .
S36:Wear suitable protective clothing .
S37/39:Wear suitable gloves and eye/face protection . | [WGK Germany ]
3
| [Hazard Note ]
Irritant | [HazardClass ]
IRRITANT | [HS Code ]
29163990 |
| Hazard Information | Back Directory | [Chemical Properties]
white to light yellow crystal powder | [Uses]
trans-3,4-Difluorocinnamic Acid is a starting material in the preparation of Ticagrelor (T437700), which is the first reversible oral P2Y12 receptor antagonist, provides faster, greater, and more consistent ADP-receptor inhibition than Clopidogrel. |
|
|